Pfizer’s Lyrica fails in phase 3 trial in epilepsy patients with PGTC seizures

This article was originally published here

Lyrica could not show a statistically significant reduction in seizure frequency in comparison to placebo in the late-stage trial held in 219 patients aged between five and 65

The post Pfizer’s Lyrica fails in phase 3 trial in epilepsy patients with PGTC seizures appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply